New Delhi, Delhi, India --- Business Wire IndiaBiotech International Limited, a New Delhi based company with over three decades of presence in the Biotechnology space in the Agriculture and Public Health reported revenue in the range of INR 100–150 crore for the financial year ended March 31, 2025. The performance was supported by demand across its agriculture and public health verticals, including biological crop protection, nutrition management and Biolarvicides. The result reflects over three decades of manufacturing depth, regulatory experience, product development and strong national and international partnerships.Company OverviewBiotech International Limited was established in 1993, giving it over three decades of experience in the Biotechnology space. The company manufactures and markets biological agricultural inputs across crop protection, crop nutrition, pest management, and soil health, including Biopesticides, Biofertilizers, Biofungicides, Bionematicides, Biostimulants, Botanicals, Bioacaricide and pheromone traps and lures. In public health, it manufactures Biolarvicides and treated bednets for mosquito larvae /vector management.The company’s products have been extensively used pan India and have been exported to number of countries. Its manufacturing base includes a PLC-equipped, fully automated fermentation facility with an annual production capacity of 2,00,000 MT and 10,000 KL of Biopesticides and Biofertilizers across multiple formulation types. Biotech International Limited holds cGMP, ISO 9001, ISO 14001, cGLP Class 1,00,000 laboratory and IMO certifications with products registered with the Insecticide Board and Fertilizer Board of India. The products are registered in various countries of Africa, Middle East, South America and Europe.Biotech International Limited is led by Managing Director Saurabh Singhal, who has spent over three decades at the helm of one of India’s oldest biological agriculture institutions. His tenure spans the full arc of the industry’s evolution in India, from its largely uncharted early years through to its current emergence as a pioneer and market leader. That depth of perspective has been built not only through the company’s internal technical, manufacturing, and commercial functions, but through active engagement at the highest levels of the global biological agriculture community